Intended for healthcare professionals

  1. Research
  2. Assessing the value of...
  3. Assessing the value of diagnostic tests: a framework for designing and evaluating trials
Research Methods & Reporting

Assessing the value of diagnostic tests: a framework for designing and evaluating trials

BMJ 2012; 344 doi: https://doi.org/10.1136/bmj.e686 (Published 21 February 2012) Cite this as: BMJ 2012;344:e686

Related articles

See more

Cited by...

  • Patient-centred outcomes of imaging tests: recommendations for patients, clinicians and researchers
  • Ultra-low-dose CT versus chest X-ray for patients suspected of pulmonary disease at the emergency department: a multicentre randomised clinical trial
  • Perceived feasibility, facilitators and barriers to incorporating point-of-care testing for SARS-CoV-2 into emergency medical services by ambulance service staff: a survey-based approach
  • Diagnostic accuracy of rapid point-of-care tests for diagnosis of current SARS-CoV-2 infections in children: a systematic review and meta-analysis
  • LiverMultiScan as an alternative to liver biopsy to monitor autoimmune hepatitis in the National Health Service in England: an economic evaluation
  • Ultra-low-dose CT versus chest X-ray for patients suspected of pulmonary disease at the emergency department: a multicentre randomised clinical trial
  • Diagnostic accuracy of novel ultrasonographic halo score for giant cell arteritis: methodological issues
  • Response to: 'Diagnostic accuracy of novel ultrasonographic halo score for giant cell arteritis: methodological issues by Ghajari and Sabour
  • 'Diagnostic downshift: clinical and system consequences of extrapolating secondary care testing tactics to primary care
  • Health Technology Assessment of Diagnostic Tests: A state of the art review of methods guidance from international organisations
  • Diagnostic accuracy of rapid point-of-care tests for diagnosis of current SARS-CoV-2 infections in children: A systematic review and meta-analysis
  • How to create PICO questions about diagnostic tests
  • Asymptomatic rapid testing for SARS-CoV-2
  • Unintended consequences: quantifying the benefits, iatrogenic harms and downstream cascade costs of musculoskeletal MRI in UK primary care
  • Diagnostics and the challenge of antimicrobial resistance: a survey of UK livestock veterinarians perceptions and practices
  • Qualitative study to explore radiologist and radiologic technologist perceptions of outcomes patients experience during imaging in the USA
  • Accuracy of Patient Health Questionnaire-9 (PHQ-9) for screening to detect major depression: individual participant data meta-analysis
  • Current and Emerging Trends in Point-of-Care Technology and Strategies for Clinical Validation and Implementation
  • Association between use of systematic reviews and national policy recommendations on screening newborn babies for rare diseases: systematic review and meta-analysis
  • Point-of-care urine culture for managing urinary tract infection in primary care: a randomised controlled trial of clinical and cost-effectiveness
  • Surrogate endpoints in global health research: still searching for killer apps and silver bullets?
  • Outcomes of non-invasive diagnostic modalities for the detection of coronary artery disease: network meta-analysis of diagnostic randomised controlled trials
  • Associations between cardiac troponin, mortality and subsequent use of cardiovascular services: differences in sex and ethnicity
  • Concerns about composite reference standards in diagnostic research
  • Test accuracy of drug and antibody assays for predicting response to antitumour necrosis factor treatment in Crohns disease: a systematic review and meta-analysis
  • Barriers to making recommendations about medical tests: a qualitative study of European guideline developers
  • The efficacy of bedside chest ultrasound: from accuracy to outcomes
  • Added Prognostic Value of Cerebrospinal Fluid Biomarkers in Predicting Decline in Memory Clinic Patients in a Prospective Cohort
  • Evidence used in model-based economic evaluations for evaluating pharmacogenetic and pharmacogenomic tests: a systematic review protocol
  • Restricting access to florbetapir: Medicare coverage criteria for diagnostics and drugs are inconsistent
  • Current Evidence and Future Perspectives on the Effective Practice of Patient-Centered Laboratory Medicine
  • The Move from Accuracy Studies to Randomized Trials in PET: Current Status and Future Directions
  • NICE recommendation on the use of pressure ulcer risk scores is flawed
  • Diagnostic Accuracy of Placental Growth Factor in Women With Suspected Preeclampsia: A Prospective Multicenter Study
  • Research and Statistics: Study Design and Data Sources
  • What is the best strategy for investigating abnormal liver function tests in primary care? Implications from a prospective study
  • Principles for high-quality, high-value testing
  • Not-So-Random Errors: Randomized Controlled Trials Are Not the Only Evidence of the Value of PET
  • Reply: Not-So-Random Errors: Randomized Controlled Trials Are Not the Only Evidence of the Value of PET
  • Effect of adding a diagnostic aid to best practice to manage suspicious pigmented lesions in primary care: randomised controlled trial
  • Testing, testing, testing
Back to top